Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
Powershares QQQApr 24, 2025
BroadcomApr 24, 2025
Alphabet AApr 24, 2025
Ultrapro Short QQQ ProApr 24, 2025
S&P 500 ETF VanguardApr 24, 2025

The market rallied Thursday, and Nasdaq Combined Composite Index closed at 17166 points after an increase of 2.7 percent. This past week the index has gained as much as 5.3 percent.

5667 shares were up and 1373 were down, while 168 remained unchanged, and there was no trading in 168 shares.

Total value of the trading volume for shares and primary capital certificates Thursday was approximately 659.0 billion.

ServiceNow closed at 939 dollar after a huge gain of 15.5 percent. The stock has never gained more in one day since we started measuring this Aug 2. 2012. Technically it also looks good. The stock is assessed as technically slightly positive for the medium long term.
Cantor Equity Partners closed at 24.80 dollar after a huge gain of 50.3 percent. This past week the stock has gained as much as 134.0 percent. It was also extremely high volume. Overall it was traded for 1332 millions dollar in the stock, which is 63 times as much as normal daily turnover. It also looks good technically. The stock is trend wise positive in the medium term, has support at 10.30 dollar and a further increase is indicated.
Netflix moved up and ended at 1097 dollar, which is an increase of 4.5 percent. The stock thereby broke the previous record from Feb 14 and set a new all time high. The stock has now closed up for the fifth day in a row. Technically it also looks good. The stock is trend wise positive in the medium term, has broken up through resistance at 1060 dollar and a further increase is indicated.
IBM closed at 229 dollar after a steep drop of 6.6 percent. The stock has never lost more in one day since Apr 25. 2024, when it was down 8.3 percent. It was also high volume. Overall it was traded for 3538 millions dollar in the stock, which is three times as much as normal daily turnover. It does not look good technically either. The stock is trend wise positive in the medium term, but has broken down through support at 235 dollar.
PepsiCo ended with a steep loss of 4.9 percent and closed at 135 dollar. We must go back to Oct 5. 2023 to find an equally steep drop. That time the stock lost 5.2 percent. The stock has by that dropped 7.3 percent since the sell signal from the rectangle formation three weeks ago.

US 500 sharply higher
The market rallied Thursday, and S&P 500 closed at 5485 points after an increase of 2.0 percent. This past week the index has gained as much as 4.0 percent.

Indices
S&P 500
arrow green   Positive Candidate
S&P 500 has broken the floor of the rising trend channel in the medium long term, which indicates a weaker initial rising rate. The index has broken a resistance level in the short term and given a positive signal for the short-term trading range. The index has support at points 5200 and resistance at points 5820. The index is overall assessed as technically positive for the medium long term.
Today´s Case
HCA Healthcare (HCA) Price 341.41, Apr 24, 2025
chart
HCA Healthcare shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. The stock has broken a resistance level in the short term and given a positive signal for the short-term trading range. The stock has broken up through resistance at dollar 334. This predicts a further rise. In case of negative reactions, there will now be support at dollar 334. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX0.27%871.99
CAC400.27%7502.78
COMPX2.74%17166.00
DAX0.47%22065
HEX-0.83%9701.34
N1000.29%1491.51
OMXC25GI-0.45%1892.93
OMXSPI0.29%915.92
OSEBX0.29%1456.43
PSI200.61%6878.47
TECDAX1.17%3583.19
BUK100P0.10%837.40
EURUSD0.16%1.1400
CL (OIL)0.84%62.79
Indices Evaluations
 SML
AEXnegpospos
CAC40negpospos
COMPXnegpospos
DAXnegpospos
HEXnegneutralneg
N100neutralpospos
OMXC25GInegnegpos
OMXSPInegnegpos
OSEBXnegnegneutral
PSI20neutralpospos
TECDAXnegpospos
BUK100Pnegneutralpos
EURUSDpospospos
CL (OIL)negnegneg

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
US Stocks - Medium term
 
      
26% 33% 41%
 1893 Buy Candidates
 2427 Neutral
 3089 Sell Candidates
Disclaimer Copyright © 2025 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Cancel Analysis News
[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.